In this episode Dr. Gillian Beauchamp sits down with Dr. Tricia Wright to discuss risk factors leading to methamphetamine use disorder, associated complications in pregnancy and management of substance use disorder in pregnant and postpartum patients. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Tricia Wright to discuss the known and theoretical risks of cannabis use during pregnancy and lactation.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Mishka Terplan to discuss stigma, discrimination and prejudice in relation to substance use in pregnancy. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Lori Devlin to discuss  Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal Syndrome (NOWS) and the treatment of NOWS. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Kurt Kleinschmidt to discuss the differences between dependence, addiction, and substance use disorder and how it relates to medication associated treatment (MAT). 

In this episode Dr. Gillian Beuachamp sits down with Assistant Chief of Police Matthew Myers to discuss the Drug Recognition Evaluation (DRE) and the Drug Influence Evaluation (DRE) assessments.

In this episode Dr. Gillian Beauchamp sits down with Patrick Harding to discuss anterograde and retrograde ethanol calculations and how they are used in forensic toxicology.

In this episode Dr. Gillian Beauchamp sits down with Dr. Laura Tormoehlen  to discuss the nuances of brain death declaration in the toxicology patient

In this episode Dr. Gillian Beauchamp sits down with Dr. Andrew Monte to discuss common nomenclature used in pharmacogenetics and pharmacogenetic factors that impact patient care in the ICU. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Brenna Farmer to discuss the process of gaining approval to use medications past their original expiration dates.